Ingeborg Dybdal Øie is on the board of Intelligent Ultrasound Group Plc and Chief Strategy Officer for Huma Therapeutics Ltd.

In the past she held the position of Chief Financial Officer & Director at CMR Surgical Ltd., Vice President-Investor Relations of Smith & Nephew PLC, Research Analyst at Goldman Sachs International, Equity Analyst at Jefferies International Ltd. (Old) and Equity Analyst at Jefferies International Ltd.

Ms. Øie received an undergraduate degree from Imperial College London and a graduate degree from London School of Hygiene & Tropical Medicine.